Exodus Point Capital Management, LP Rubius Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.46 - $1.29 $4,628 - $12,978	-10,061 Closed	0 $0
Q2 2022 Aug 19, 2022	SELL	$0.79 - $5.98 $6,840 - $51,780	-8,659 Reduced 46.26%	10,061 $9,000
Q1 2022 May 13, 2022	BUY	$4.25 - $10.4 $79,560 - $194,688	18,720 New	18,720 $103,000
Q1 2021 May 17, 2021	SELL	$8.02 - $32.01 $159,790 - $637,767	-19,924 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.23 - $8.73 $84,278 - $173,936	19,924 New	19,924 $151,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.